Dax

Dax Hayden Recognized as the 2023 RLI APEX National Broker of the Year in Ag Land Ranch Sales

Retrieved on: 
Thursday, March 21, 2024

Windsor, CO, March 21, 2024 (GLOBE NEWSWIRE) -- Dax Hayden, with Hayden Outdoors Real Estate in Windsor, CO, has been recognized as the APEX 2023 National Broker of the Year in Ag Land Ranch Sales by the REALTORS® Land Institute as a part of the RLI APEX Production Awards Program, sponsored by The Land Report.

Key Points: 
  • Windsor, CO, March 21, 2024 (GLOBE NEWSWIRE) -- Dax Hayden, with Hayden Outdoors Real Estate in Windsor, CO, has been recognized as the APEX 2023 National Broker of the Year in Ag Land Ranch Sales by the REALTORS® Land Institute as a part of the RLI APEX Production Awards Program, sponsored by The Land Report.
  • This is the 2nd year in a row the Kansas native has outsold the country in Ranch land sales.
  • Dax is joined by many other agents within Hayden Outdoors Real Estate that have sold a tremendous amount of land in 2023.
  • Forty two agents and brokers had sold over $5 Million in land sales within the brokerage in 2023, helping the brokerage to over $1 Billion in land sales in 2023 and over $5 Billion since 2019.

EQS-News: Deutsche Beteiligungs AG: High activity and continued progress

Retrieved on: 
Thursday, February 8, 2024

Deutsche Beteiligungs AG (DBAG) reported an eventful first quarter of the 2023/2024 financial year, during which it integrated ELF Capital Group following a majority takeover.

Key Points: 
  • Deutsche Beteiligungs AG (DBAG) reported an eventful first quarter of the 2023/2024 financial year, during which it integrated ELF Capital Group following a majority takeover.
  • With this investment, DBAG has strengthened its position as a financing partner to mid-sized enterprises and is now even better placed to serve their financing needs.
  • DBAG has also received high approval for its updated distribution policy, which provides for a stable dividend of at least 1.00 euro for each DBAG share entitled to dividends.
  • Deutsche Beteiligungs AG (“DBAG”) has been listed since 1985 and is one of the most renowned private equity firms in Germany.

EQS-News: BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle

Retrieved on: 
Tuesday, January 30, 2024

Media release as at January 19, 2024

Key Points: 
  • Media release as at January 19, 2024
    Portfolio of BB Biotech AG as at December 31, 2023
    In 2023, global equity performed better than anticipated by many.
  • Consequently, BB Biotech ended the year with a net loss of CHF 207 mn.
  • This represents a 5% return based on the volume-weighted average closing price of BB Biotech shares in December 2023.
  • The US central bank held rates steady in the fall, lifting market sentiment in the last two months of 2023.

EQS-News: SUSS MicroTec joins the SDax

Retrieved on: 
Tuesday, May 9, 2023

Garching, May 8, 2023 – SÜSS MicroTec SE, a leading manufacturer of equipment and process solutions for the semiconductor industry and related markets, will be listed in the SDax starting tomorrow (Tuesday, May 9, 2023).

Key Points: 
  • Garching, May 8, 2023 – SÜSS MicroTec SE, a leading manufacturer of equipment and process solutions for the semiconductor industry and related markets, will be listed in the SDax starting tomorrow (Tuesday, May 9, 2023).
  • This decision was made public last Thursday evening by the German Stock Exchange via its index provider Qontigo.
  • This means that SUSS MicroTec is once again one of the 70 largest companies next to the Dax and MDax selection indexes with regard to the free float market capitalization.
  • Because of that, SMA Solar Technology AG moved up from the SDax to the MDax and SÜSS MicroTec SE is taking over the resulting free space in the SDax.

EQS-News: Cautious growth: SHS Medical Technology Index grows slightly in second year of Corona crisis

Retrieved on: 
Sunday, January 22, 2023

The SHS Medical Technology Index has returned to growth mode in the second year of the pandemic, albeit modestly.

Key Points: 
  • The SHS Medical Technology Index has returned to growth mode in the second year of the pandemic, albeit modestly.
  • The SHS Medical Technology Index, which was compiled for the first time in 2019, tracks the growth capacity, innovative strength and economic performance of the medical technology sector since 2010 in comparison to the economy as a whole.
  • The slight overall increase in the medical technology index is due to several factors that are included in the index calculation.
  • The SHS Medical Technology Index was developed by SHS Gesellschaft für Beteiligungsmanagement in cooperation with Professor Dr Christian Koziol of the Eberhard Karls University in Tübingen.

DGAP-News: PVA TePla AG moves up to S-DAX

Retrieved on: 
Monday, September 6, 2021

PVA TePla AG (FWB: TPE), Wettenberg, has made the leap to the S-Dax and will be listed in this segment from 20 September 2021, Deutsche Brse announced last Friday evening in Frankfurt am Main.

Key Points: 
  • PVA TePla AG (FWB: TPE), Wettenberg, has made the leap to the S-Dax and will be listed in this segment from 20 September 2021, Deutsche Brse announced last Friday evening in Frankfurt am Main.
  • The company is an important producer of equipment for the semiconductor industry, particularly in the areas of quality inspection and crystal growth for wafer production.
  • The stock market value of PVA TePla AG is currently around EUR 740 million, 86 percent of which is relevant for index selection according to the criteria of Deutsche Brse as so-called free float.
  • It is also an expression of the fact that we are very well positioned with our product solutions for the semiconductor industry - particularly in the areas of crystal growth and quality inspection," says Manfred Bender, CEO of PVA TePla AG.

Sartorius To Join The DAX Blue Chip Index

Retrieved on: 
Saturday, September 4, 2021

GTTINGEN, Germany, Sept. 4, 2021 /PRNewswire/ -- The life science group Sartorius will be admitted to the German DAX blue chip index.

Key Points: 
  • GTTINGEN, Germany, Sept. 4, 2021 /PRNewswire/ -- The life science group Sartorius will be admitted to the German DAX blue chip index.
  • In addition, Sartorius preference shares will continue to be listed on the TecDAX, the leading index of the German technology stocks.
  • Membership in the DAX shows the increasing importance of the biotech and life science sectors and puts Sartorius even more in the public eye.
  • Thus, approximately one-third of Sartorius' total market capitalization will be taken into account for determining membership in the DAX.